![Viruses | Free Full-Text | HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons | HTML Viruses | Free Full-Text | HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons | HTML](https://www.mdpi.com/viruses/viruses-14-00482/article_deploy/html/images/viruses-14-00482-g003.png)
Viruses | Free Full-Text | HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons | HTML
![HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection](http://www.hcv-trials.com/studies/C-ISLE/Diapositive5.jpg)
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data | PLOS ONE
![Retrospective multicentre study on the effectiveness of first‐line direct‐acting antivirals against hepatitis C virus genotype‐1 - Kaya - - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library Retrospective multicentre study on the effectiveness of first‐line direct‐acting antivirals against hepatitis C virus genotype‐1 - Kaya - - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/74ca3668-e204-4719-b85d-f13b16298471/jcpt13624-fig-0001-m.jpg)
Retrospective multicentre study on the effectiveness of first‐line direct‐acting antivirals against hepatitis C virus genotype‐1 - Kaya - - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
![Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis | Journal of Pharmaceutical Health Care and Sciences | Full Text Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis | Journal of Pharmaceutical Health Care and Sciences | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40780-018-0113-3/MediaObjects/40780_2018_113_Fig2_HTML.png)
Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis | Journal of Pharmaceutical Health Care and Sciences | Full Text
![Cost-Utility of Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Genotype 1 Infection - ScienceDirect Cost-Utility of Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Genotype 1 Infection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1098301517302498-gr2.jpg)
Cost-Utility of Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Genotype 1 Infection - ScienceDirect
![Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure - Journal of Hepatology Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f9a87416-a53a-4fe9-ae5a-0332f588909e/gr4.jpg)